Clin2
NCT07293559Possibly a fitRecruiting

Understanding infant feeding choices in women with HIV

HIV-1-infectionBreastfeedingPregnancy Related

Part of Infections, Women’s health & pregnancy clinical trials.

This study looks at how women with HIV decide whether to breastfeed, and what support they get from healthcare providers and family. It aims to learn about their experiences and needs.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
1,150 people
Ages
Any age
Study type
Observational

Who can take part

  • You are a woman with HIV who is pregnant or gave birth after February 28, 2023
  • You are at least 28 weeks pregnant or have given birth recently
  • You can provide your own consent to join the study
  • You are willing to talk about your infant feeding plans or experiences
  • If needed, you can use a translator to participate in interviews

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06955715Recruiting
Pasteurized donor milk for HIV-exposed babies: a pilot study

This study tests if pasteurized donor human milk is a safe and acceptable option for infants exposed to HIV. It may help families who cannot or choose not to breastfeed.

Saskatoon, Saskatchewan
NCT06506188Recruiting
Improving HIV prevention for breastfeeding women in Malawi

This study looks at how to make it easier for women in Malawi to stay on PrEP after giving birth while breastfeeding. Researchers will check medical records and ask some women to do a short survey and a finger stick blood test.

Lilongwe
NCT06517693Recruiting· Phase 1
HIV antibody safety study for newborns at risk

This study tests whether giving a combination of two lab-made antibodies (PGT121.414.LS and VRC07-523LS) to newborns exposed to HIV during pregnancy is safe and how the body processes them. It may help protect infants from getting HIV after birth.

Los Angeles, California
NCT02140255Recruiting· Phase 1/Phase 2
Intensive early HIV treatment in newborns to aim for remission

This study gives very early, intensive HIV medicine to infants diagnosed with HIV and follows them closely to see if HIV can go into remission (stop being detectable without ongoing treatment). It may help families understand whether treating right after birth can change a child’s long-term HIV outlook.

La Jolla, California
NCT07064928Enrolling by invitation
Reducing HIV stigma in pregnancy and after birth

This study tests a program to reduce stigma related to HIV among pregnant women and new mothers. You may be eligible if you are living with HIV, are between 24 and 36 weeks pregnant, and plan to stay in the area for at least 6 months after your baby is born.

Accra
NCT06666530Recruiting
Quality of life for pregnant women with HIV

This study looks at how being pregnant while living with HIV affects your quality of life and the care you receive. It aims to understand your experiences and needs during this time.

Paris

Hear when a new HIV-1-infection trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.